Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects Of Candesartan Cilexetil vs Standard Therapy on Serum Levels of Brain Natriuretic Peptide in Patients Suffering From Chronic Heart Failure With Depressed and Preserved Systolic Function

NCT00843154 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00843154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00843154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects Of Candesartan Cilexetil vs Standard Therapy on Serum Levels of Brain Natriuretic Peptide in Patients Suffering From Chronic Heart Failure With Depressed and Preserved Systolic Function
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2005
Completion date
July 31, 2008
Enrollment
571 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure